Floatz logo

Capsaicin

Neuralgia, Postherpetic

Astellas Pharma Europe Ltd.Small moleculePhase 4 / ApprovedDormant
BBB
77/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
65/ 100
Competitive Position
95/ 100

Competitive context

19 Active assets in the Neuralgia, Postherpetic cohort.

Asset / SponsorPhaseRating
LIDOCAINE
Seoul National University Hospital
Phase 4BBB
Pregabalin
Neurodawn Pharmaceutical Co., Ltd.
Phase 4BBB
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
University of Medicine and Pharmacy at Ho Chi Minh City
Phase 4BBB
Capsaicin
Astellas Pharma Europe Ltd.
Phase 4BBB
(±)-TRAMADOL
Astellas Pharma Inc
Phase 4BB

View all 50 →

Same molecule, other indications

Capsaicin is also rated in:

peripheral nervous system disorderDormant
A
Indicative ·
81 / 100
View asset →
diabetic neuropathyDormant
BBB
Indicative ·
78 / 100
View asset →
neuralgiaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →